CTSOVSGTBP• 6 Months (Normalized)
CTSO vs GTBP (Cytosorbents Corporation vs GT Biopharma Inc.)
Showing Closing Date Range from Apr 1 to Sep 28, 2026.
Normalized cumulative comparison anchored at 0.00% baseline to illustrate pure alpha, return divergence, and market momentum.
CTSO Performance $4.91
+797.62%
Cytosorbents Corporation
Normalized Baseline0.00%
GTBP Performance $7.1
+1635.94%
GT Biopharma Inc.
Normalized Baseline0.00%
Alpha Spread Margin GTBP LEADS
-838.32 pts
GTBP outperforming by 838.32 percentage points
CTSOGTBP
Spread Trajectory6 Months (Normalized)
Cumulative Performance Trajectory
Interactive divergence comparison normalized at 0.00% on start date.
CTSO GTBP
Comparative Historical Ledger
Daily closing prices, normalized percentages, and relative spread divergence.
Historical Quotes & Breakdown(119 dates)
| Date | CTSO Price | CTSO Gain (%) | GTBP Price | GTBP Gain (%) | Spread |
|---|---|---|---|---|---|
| Sep 23, 2026 | $4.91 | +797.62% | $7.10 | +1635.94% | -838.32% |
| Sep 21, 2026 | $5.51 | +907.31% | $7.18 | +1655.50% | -748.19% |
| Sep 18, 2026 | $5.75 | +951.19% | $7.16 | +1650.61% | -699.42% |
| Sep 17, 2026 | $5.76 | +953.02% | $7.49 | +1731.30% | -778.28% |
| Sep 16, 2026 | $5.73 | +947.53% | $7.81 | +1809.54% | -862.01% |
| Sep 15, 2026 | $6.06 | +1007.86% | $9.00 | +2100.49% | -1092.63% |
| Sep 14, 2026 | $6.07 | +1009.69% | $11.63 | +2743.52% | -1733.83% |
| Sep 11, 2026 | $6.41 | +1071.85% | $8.61 | +2005.13% | -933.28% |
| Sep 10, 2026 | $6.37 | +1064.53% | $6.18 | +1411.00% | -346.47% |
| Sep 09, 2026 | $6.33 | +1057.22% | $5.98 | +1362.10% | -304.88% |
| Sep 04, 2026 | $0.35 | -36.01% | $0.24 | -41.08% | +5.07% |
| Sep 03, 2026 | $0.35 | -36.01% | $0.25 | -38.39% | +2.38% |
| Sep 02, 2026 | $0.38 | -29.80% | $0.28 | -30.81% | +1.01% |
| Sep 01, 2026 | $0.34 | -38.21% | $0.29 | -29.34% | -8.87% |
| Aug 31, 2026 | $0.34 | -37.66% | $0.29 | -30.07% | -7.59% |
Page 1 of 8